Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biotage Board/Management Information 2023

Apr 28, 2023

2894_rns_2023-04-28_1e4c87ea-f5c4-41ff-aa1b-daa93af00830.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Maja Nilsson has today informed Biotage that she is leaving the position as CFO.

Maja Nilsson has a six months' notice period. The company will now initiate the recruitment of a successor.

This information was submitted for publication, through the agency of the contact persons set out above, at 15.00 CET on April 28, 2023.

Contacts

Tomas Blomquist, President and CEO Tel: 0705 23 01 63, [email protected]

About Biotage

Biotage is a Global Impact Tech Company committed to solving society's problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs over 500 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage's share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm. Website: www.biotage.com

Attachments

Maja Nilsson has today informed Biotage that she is leaving the position as CFO.